SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 414 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2024. The put-call ratio across all filers is 0.26 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $9,310,466 | +22.1% | 58,927 | +0.1% | 0.03% | +21.7% |
Q1 2024 | $7,624,417 | -32.9% | 58,894 | -50.0% | 0.02% | +27.8% |
Q4 2023 | $11,355,404 | +55.3% | 117,758 | +95.3% | 0.02% | -30.8% |
Q3 2023 | $7,310,051 | +5.5% | 60,304 | -0.4% | 0.03% | +13.0% |
Q2 2023 | $6,930,521 | -15.8% | 60,518 | +1.4% | 0.02% | -17.9% |
Q1 2023 | $8,226,384 | -34.9% | 59,685 | -38.8% | 0.03% | -39.1% |
Q4 2022 | $12,643,639 | -41.7% | 97,574 | -50.3% | 0.05% | +7.0% |
Q3 2022 | $21,689,527 | +48.1% | 196,210 | +0.4% | 0.04% | +59.3% |
Q2 2022 | $14,645,992 | -5.9% | 195,384 | -1.9% | 0.03% | +22.7% |
Q1 2022 | $15,560,440 | +73.5% | 199,192 | +100.0% | 0.02% | -4.3% |
Q4 2021 | $8,969,000 | -1.5% | 99,597 | +1.2% | 0.02% | -11.5% |
Q3 2021 | $9,101,000 | -38.2% | 98,407 | -48.1% | 0.03% | +23.8% |
Q2 2021 | $14,738,000 | +93.9% | 189,580 | +85.9% | 0.02% | -8.7% |
Q1 2021 | $7,601,000 | -38.0% | 101,989 | +41.9% | 0.02% | -39.5% |
Q4 2020 | $12,255,000 | +26.5% | 71,882 | +4.2% | 0.04% | +8.6% |
Q3 2020 | $9,688,000 | -59.7% | 68,985 | -54.0% | 0.04% | -25.5% |
Q2 2020 | $24,048,000 | +84.4% | 149,980 | +12.5% | 0.05% | +42.4% |
Q1 2020 | $13,044,000 | -19.7% | 133,342 | +5.9% | 0.03% | 0.0% |
Q4 2019 | $16,248,000 | +75.4% | 125,912 | +2.4% | 0.03% | +83.3% |
Q3 2019 | $9,262,000 | -50.5% | 122,972 | -0.2% | 0.02% | -51.4% |
Q2 2019 | $18,716,000 | +90.7% | 123,170 | +49.5% | 0.04% | -2.6% |
Q1 2019 | $9,816,000 | +3.4% | 82,361 | -5.3% | 0.04% | -7.3% |
Q4 2018 | $9,490,000 | -32.5% | 86,961 | -0.1% | 0.04% | -21.2% |
Q3 2018 | $14,061,000 | +22.1% | 87,061 | -0.1% | 0.05% | +18.2% |
Q2 2018 | $11,514,000 | +160.8% | 87,107 | +46.2% | 0.04% | +144.4% |
Q1 2018 | $4,415,000 | +261.6% | 59,593 | -29.4% | 0.02% | +260.0% |
Q4 2014 | $1,221,000 | – | 84,400 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Evolutionary Tree Capital Management, LLC | 68,937 | $5,138,000 | 3.04% |
Avoro Capital Advisors LLC | 2,150,000 | $160,240,000 | 2.77% |
Casdin Capital, LLC | 550,000 | $40,992,000 | 1.22% |
TOBAM | 371,107 | $27,659,000 | 1.18% |
Ikarian Capital, LLC | 455,900 | $33,978,000 | 1.14% |
Eventide Asset Management | 697,156 | $51,959,000 | 0.77% |
FOX RUN MANAGEMENT, L.L.C. | 4,902 | $365,000 | 0.66% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 31,500 | $2,348,000 | 0.62% |
Sivik Global Healthcare LLC | 20,000 | $1,491,000 | 0.54% |
Rock Springs Capital Management LP | 328,750 | $24,502,000 | 0.54% |